Bruker Corp
BRKR
Market Cap$5.77B
Close$
$63.74
64.6% upside
Current Fair Value
64.6% upsideUndervalued by 64.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.77 Billion |
|---|---|
| Enterprise Value | $8.17 Billion |
| Dividend Yield | $0.2 (0.5252100840336129%) |
| Earnings per Share | $0.76 |
| Beta | 1.16 |
| Outstanding Shares | 151,600,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 72.52 |
|---|---|
| PEG | -110.19 |
| Price to Sales | 1.76 |
| Price to Book Ratio | 3.23 |
| Enterprise Value to Revenue | 2.37 |
| Enterprise Value to EBIT | 50.62 |
| Enterprise Value to Net Income | 102 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 1.42 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bruker Corp
6,000 employees
CEO: Frank Laukien Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...